Resmed (RMD) announced the publication of a meta-analysis in The Lancet Respiratory Medicine, demonstrating that CPAP therapy significantly reduces the risk of death for people with obstructive ...

SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD ... demonstrating that CPAP therapy significantly reduces the risk of death for people with obstructive sleep apnea (OSA).